MedPath

A randomised controlled trial to evaluate the efficacy and cost-effectiveness of counselling in patients with chronic depression and anxiety

Not Applicable
Completed
Conditions
Mental and behavioural disorders: Depression, anxiety, neuroses
Mental and Behavioural Disorders
Depression
Registration Number
ISRCTN93023252
Lead Sponsor
Department of Health (UK)
Brief Summary

2000 results in:HTA monograph) in: http://www.ncbi.nlm.nih.gov/pubmed/11134918

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
181
Inclusion Criteria

Patients were screened at GP practices and asked to participate if they scored 14 on the Beck Depression Inventory (BDI), had suffered depression or depression/anxiety for 6 months or more, were aged 18-70 and had no history of drug or alcohol abuse, psychosis or suicidal tendencies.

Exclusion Criteria

Not provided at time of registration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main outcome measure was the BDI. Others included the Brief Symptom Inventory, the Inventory of Interpersonal Problems and the Social Adjustment Scale. All tests were given at initial, 6- and 12-month assessments. Comprehensive costs were also estimated, and combined with changes in outcomes to examine between-group differences and whether counselling was more cost-effective than standard GP care.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration.
© Copyright 2025. All Rights Reserved by MedPath